GlassScriptPhysician profile
Laura Copaken
NPI 1043268642
$354.06
in general payments reported to CMS, 2019-2025
14 companies · $54.91 in 2025
The $54.91 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.80 · 2022: $52.57 · 2023: $78.54 · 2024: $99.24 · 2025: $54.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $61.79 | 2019-2022 | |
| Heron Therapeutics, INC. | $41.12 | 2023-2024 | Zynrelef |
| Bioventus LLC | $39.36 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $27.54 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Treace Medical Concepts, INC. | $27.48 | 2024 | |
| Celgene Corporation | $21.22 | 2019 | |
| Amgen INC. | $20.84 | 2019 | |
| Pfizer INC. | $18.20 | 2024 | |
| Almatica Pharma LLC | $17.65 | 2025 | Teriparatide |
| Fresenius Kabi USA, LLC | $17.64 | 2023 | Idacio |
| Abbvie INC. | $17.52 | 2022 | |
| Ani Pharmaceuticals, INC. | $16.86 | 2024 | Purified Cortrophin Gel |
| Radius Health, INC. | $14.08 | 2025 | Tymlos |
| Electronic Waveform Lab, INC. | $12.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Copaken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.